GHIGLIERI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.323
AS - Asia 941
EU - Europa 243
SA - Sud America 46
Continente sconosciuto - Info sul continente non disponibili 20
AF - Africa 13
OC - Oceania 10
Totale 2.596
Nazione #
US - Stati Uniti d'America 1.162
TR - Turchia 348
CN - Cina 275
SG - Singapore 265
CA - Canada 157
IT - Italia 97
BR - Brasile 42
DE - Germania 40
GB - Regno Unito 30
IE - Irlanda 22
EU - Europa 20
IN - India 13
RO - Romania 10
RU - Federazione Russa 9
FI - Finlandia 7
AU - Australia 6
FR - Francia 6
TW - Taiwan 6
BD - Bangladesh 5
HK - Hong Kong 5
NL - Olanda 5
JP - Giappone 4
NZ - Nuova Zelanda 4
EG - Egitto 3
SC - Seychelles 3
UA - Ucraina 3
ZA - Sudafrica 3
BE - Belgio 2
DK - Danimarca 2
ES - Italia 2
JO - Giordania 2
KE - Kenya 2
LK - Sri Lanka 2
MX - Messico 2
PH - Filippine 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PK - Pakistan 1
PL - Polonia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.596
Città #
Kocaeli 269
San Mateo 229
Toronto 147
Santa Clara 95
Houston 92
Singapore 83
Lawrence 79
Princeton 79
Wilmington 77
Chandler 63
Beijing 36
Fairfield 33
Shanghai 32
Redwood City 23
Ashburn 22
Guangzhou 22
Woodbridge 22
Rome 19
Assago 18
The Dalles 18
Los Angeles 15
Seattle 15
Shenzhen 14
Dublin 12
Constanta 10
Falls Church 10
West Jordan 10
Jiaxing 9
Dallas 8
Cambridge 7
Council Bluffs 7
Frankfurt am Main 7
Chicago 6
Helsinki 6
Bristol 5
Hong Kong 5
Pune 5
Munich 4
Rui'an 4
Suffern 4
Taipei 4
Wuhan 4
Wuxi 4
Brooklyn 3
Dhaka 3
Jinhua 3
Redmond 3
São Paulo 3
Tokyo 3
Trento 3
Weitang 3
Amman 2
Atlanta 2
Belo Horizonte 2
Bolzano 2
Calgary 2
Dongyang 2
Genoa 2
Imola 2
Leicester 2
London 2
Montreal 2
Nanjing 2
Nantong 2
New York 2
Palmerston North 2
Pesaro 2
Santo André 2
Shaoxing 2
Stockholm 2
Tianjin 2
Tongchuanshi 2
Turin 2
Wuhu 2
Xi'an 2
Zhengzhou 2
Agadir 1
Airdrie 1
Ann Arbor 1
Apucarana 1
Araçatuba 1
Arcore 1
Aryanah 1
Auchterarder 1
Baku 1
Bangalore 1
Baoding 1
Bengbu 1
Berkeley 1
Berlin 1
Bloomfield 1
Boardman 1
Bordeaux 1
Brasília 1
Brattvåg 1
Brentford 1
Bridgetown 1
Buenos Aires 1
Buffalo 1
Cajamar 1
Totale 1.731
Nome #
Direct and indirect pathways of basal ganglia: a critical reappraisal 168
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease 85
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 57
Dopamine drives binge-like consumption of a palatable food in experimental parkinsonism. 50
Theta-burst stimulation and striatal plasticity in experimental parkinsonism 49
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 49
NMDA receptor G1uN2D subunit participates to levodopa-induced dyskinesia pathophysiology 48
Interaction between basal ganglia and limbic circuits in learning and memory processes 47
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuo-spatial memory alteration. 47
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap 47
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 46
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease 46
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 45
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 44
Neural networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 44
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression 43
Striatum-hippocampus balance: From physiological behavior to interneuronal pathology 43
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D-2/A(2A) Receptor Interaction in the Striatum: Implications for Parkinson's Disease 43
Prenatal stress and hippocampal BDNF expression: a fading imperative 43
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 42
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 42
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? 41
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment 41
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice 40
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 39
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia 39
Striatal spreading depolarization: possible implication in L-DOPA-induced dyskinetic like-behavior. 39
Molecular mechanisms underlying levodopa-induced dyskinesia. 39
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease 39
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 39
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP 38
Hyperkinetic disorders and loss of synaptic downscaling 38
Intermittent Theta-burst Stimulation Rescues Dopamine-Dependent Corticostriatal Synaptic Plasticity and Motor Behavior in Experimental Parkinsonism: Possible Role of Glial Activity 38
FUNCTIONAL INTERACTIONS WITHIN STRIATAL MICROCIRCUIT IN ANIMAL MODELS OF HUNTINGTON'S DISEASE 37
The endocannabinoid system in Parkinson's disease. 37
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 36
Plastic abnormalities in experimental Huntington's disease 36
Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease 34
L-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via beta-adrenergic receptors 34
Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory 33
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia 33
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 33
L-3,4-Dihydroxyphenylalanine-Induced Sprouting of Serotonin Axon Terminals: A Useful Biomarker for Dyskinesias? 32
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition 31
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion 31
Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD. 30
Direct and indirect pathways in levodopa-induced dyskinesia: a more complex matter than a network imbalance. 30
Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease 25
"Lazy" nigrostriatal synapses in the heterozygous PINK1 mouse model of familial Parkinson's disease 22
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of L-Dopa-induced dyskinesia 21
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease 21
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 21
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 20
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease 19
Attachment and parental reflective functioning features in ADHD: Enhancing the knowledge on parenting characteristics 19
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction 18
Le emozioni nei contesti individuali e sociali 18
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 17
Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion 17
Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia 16
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence 15
Serotonin drives striatal synaptic plasticity in a sex-related manner 15
Cigarette smoke inhalation stimulates dopaminergic neurons in rats 14
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease 14
Alpha-synuclein: From early synaptic dysfunction to neurodegeneration 13
Environmental enrichment repairs structural and functional plasticity in the hippocampus 13
Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle-Brain Axis 13
Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release 13
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 13
Maternal stress programs accelerated aging of the basal ganglia motor system in offspring 13
Neurofunctional effects of developmental alcohol exposure in alcohol-preferring and alcohol-nonpreferring rats 12
Striatal glutamatergic hyperactivity in Parkinson's disease 12
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease 12
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation 12
Synaptic dysfunction in Parkinson's disease 12
Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat 12
TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid 12
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 12
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease 12
Long-Term Shaping of Corticostriatal Synaptic Activity by Acute Fasting 12
Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury 11
Hippocampal enlargement in Bassoon-mutant mice is associated with enhanced neurogenesis, reduced apoptosis, and abnormal BDNF levels 11
Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease 11
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 11
Impairment of long term depression in dyskinetic rats: A critical role of NO/cGMP pathway in recovering synaptic plasticity 11
Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction 10
Rhes, a key element of selective neuronal vulnerability in Huntington's disease: a striatal-specific license to kill during energy metabolism failure 10
Astrocyte Responses Influence Local Effects of Whole‐Brain Magnetic Stimulation in Parkinsonian Rats 10
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit 10
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity 10
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 9
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease 8
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 7
Environmental Enrichment and Functional Plasticity in the Hippocampus – An Update on the Mechanisms Involved 7
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation 6
Totale 2.717
Categoria #
all - tutte 34.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 0 0 0 0 0 0 0 50
2020/2021513 40 22 8 10 20 41 31 11 16 24 269 21
2021/2022507 10 141 143 0 3 7 18 50 27 92 9 7
2022/2023336 178 2 3 20 30 6 4 8 15 21 40 9
2023/2024252 0 2 11 60 8 7 1 3 8 25 20 107
2024/2025826 36 205 46 21 40 148 26 76 102 13 42 71
Totale 2.717